EBIT at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s EBIT?
- Nurix Therapeutics, Inc. (NRIX) reported EBIT of -$92.5M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s EBIT changed year-over-year?
- Nurix Therapeutics, Inc.'s EBIT decreased by 47.1% year-over-year, from -$62.86M to -$92.5M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s EBIT has grown at a 24.8% compound annual growth rate (CAGR), from -$117.89M to -$285.67M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.